mentioned.fm

Bristol Myers Squibb

Mentioned 1 time across 1 podcast this week

This Week's Pulse

Bristol Myers Squibb has initiated a massive internal shift, announcing a partnership to deploy Anthropic’s Claude AI across its global workforce of 30,000 employees. This follows a flurry of activity for the firm, including a major oncology collaboration with Hengrui Pharma and a European regulatory win for Sotyktu.

On On with Kara Swisher, Joanna Stern highlighted the company's aggressive commitment to computational infrastructure, noting, "There are millions of dollars in GPUs standing behind me, and they're looking for new drug discovery." The sentiment underscores the pivot from traditional lab-bench methodology to high-compute reliance in pharmaceutical development.

While the technical community is bullish on the integration of these models, the market is watching closely to see if the Bristol Myers Squibb pipeline—discussed recently at the Bank of America Securities Healthcare Conference—can deliver the efficiency gains promised by this massive AI deployment.

Where it's discussed

Joanna Stern Turned Her Life Over to AI For A Year — Here’s What She Learned

On with Kara Swisher

Joanna Sternpositivefrom “AI in Healthcare and Personal Boundaries”

The company utilizes data centers with millions of dollars in GPUs for drug discovery research.

“These are specialized models where they're applying a lot of compute, as we talked about. Um, in fact, I go to the data center in one of the chapters, and it's a Bristol Myers Squibb data s- I mean, the GPUs. There are millions of dollars in GPUs standing behi…”